1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Stage IIA Melanoma: new trials by email Literature Review of Stage IIA Melanoma trials Research Report on Stage IIA Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma sargramostim, sentinel lymph node biopsy, laboratory biomarker analysis - Stage IB Melanoma, Stage IIA Melanoma | Phase 3 | Withdrawn | Jonsson Comprehensive Cancer Center | 2011-08-05 | 2020-07-27 |
Melanoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Skin Diseases (1) · Skin Neoplasms (1) · Skin and Connective Tissue Diseases (1)
Granulocyte-Macrophage Colony-Stimulating Factor (1) · Saline Solution, Hypertonic (1) · Sentinel Lymph Node Biopsy (1) · sargramostim (1)
Jonsson Comprehensive Cancer Center (1)
United States (1)
Richard Essner (1)
R01CA120228 (1)